Perrigo’s stock soars 6% after FDA approves its over-the-counter daily oral contraceptive

Perrigo Co. PLC’s stock
PRGO,
+4.53%
soared 6% in premarket trade Thursday, after the company said the U.S. Food and Drug Administration has approved its over-the-counter daily oral contraceptive. The move was expected after an FDA advisory panel voted overwhelmingly in favor of the pill called opill, which is the first OTC contraceptive to be approved in the U.S.